| 000 | 01825 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517162353.0 | ||
| 264 | 0 | _c20180529 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1878-4216 | ||
| 024 | 7 |
_a10.1016/j.pnpbp.2017.06.034 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAhmad, Sheikh F | |
| 245 | 0 | 0 |
_aToll-like receptors, NF-κB, and IL-27 mediate adenosine A2A receptor signaling in BTBR T _h[electronic resource] |
| 260 |
_bProgress in neuro-psychopharmacology & biological psychiatry _c10 2017 |
||
| 300 |
_a184-191 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenosine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAdenosine A2 Receptor Agonists _xpharmacology |
| 650 | 0 | 4 |
_aAdenosine A2 Receptor Antagonists _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAutistic Disorder _xdrug therapy |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aInterleukins _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aNeuroimmunomodulation _xdrug effects |
| 650 | 0 | 4 |
_aPhenethylamines _xpharmacology |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 |
_aReceptor, Adenosine A2A _xmetabolism |
| 650 | 0 | 4 |
_aToll-Like Receptors _xmetabolism |
| 650 | 0 | 4 |
_aTriazoles _xpharmacology |
| 700 | 1 | _aAnsari, Mushtaq A | |
| 700 | 1 | _aNadeem, Ahmed | |
| 700 | 1 | _aBakheet, Saleh A | |
| 700 | 1 | _aAl-Ayadhi, Laila Yousef | |
| 700 | 1 | _aAttia, Sabry M | |
| 773 | 0 |
_tProgress in neuro-psychopharmacology & biological psychiatry _gvol. 79 _gno. Pt B _gp. 184-191 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pnpbp.2017.06.034 _zAvailable from publisher's website |
| 999 |
_c27329912 _d27329912 |
||